Neovasc Inc. NVCN
Day range unavailable
52-week range unavailable
- Market cap
- 83.59M
- Shares out
- 2.76M
- Forward P/E
- -2.91
- Analysts
- Hold
- Price target
- 24.00 (-20.1%)
- Earnings date
- May 11, 2023
6M +23.53 (+362.00%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 2.94
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 1.05%
- 50-day average
- 29.31
- 200-day average
- 15.47
Analyst view
Consensus: hold
- Target (low)
- 20.00
- Target (mean)
- 24.00
- Target (high)
- 28.00
- Strong buy1
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
May 11, 2023
Expected May 11, 2023. Consensus EPS estimate -2.71.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 11, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Mar 31, 2023 | Dec 1, 2022 | -1.93 | — | — | — |
| Nov 10, 2022 | Sep 1, 2022 | -2.82 | — | — | — |
| Aug 11, 2022 | Jun 1, 2022 | -1.25 | — | — | — |
| May 12, 2022 | Mar 1, 2022 | -1.25 | — | — | — |
| Mar 10, 2022 | Dec 1, 2021 | -2.50 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2020 | SVB Leerink | main | — | Outperform |
| Nov 25, 2020 | H.C. Wainwright | reit | — | Buy |
| Nov 25, 2020 | Canaccord Genuity | main | — | Buy |
| Nov 25, 2020 | H.C. Wainwright | init | — | Buy |
| Nov 25, 2020 | Leerink Swann | main | Outperform | Outperform |
| Nov 25, 2020 | Canaccord Genuity | main | Buy | Buy |
About Neovasc Inc.
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Canada
- Website
- neovasc.com
News
Stocks That Hit 52-Week Lows On Friday 
Earnings Scheduled For November 10, 2022 - Earnings Scheduled For August 11, 2022
Earnings Scheduled For May 12, 2022 - 74 Biggest Movers From Yesterday
Stocks That Hit 52-Week Lows On Thursday - Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Tuesday - Earnings Scheduled For March 10, 2022
- The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Your note
Sign in to keep a note on NVCN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Becker (Lisa Ann McFadde) | Senior Officer of Issuer | Exercise of rights | Aug 17, 2022 | 2,451 |
| Clark, Christopher John | Senior Officer of Issuer | Exercise of rights | Jun 21, 2022 | 49,095 |
| Colen (Fredericus A) | Senior Officer of Issuer | Exercise of rights | Jun 21, 2022 | 224,154 |
| Gallagher (Sarah Marie Hodgson) | Senior Officer of Issuer | Exercise of rights | Aug 17, 2022 | 1,458 |
| Geyer (Paul) | 10% Security Holder of Issuer | Acquisition or disposition in the public market | Nov 17, 2022 | 18,335 |
| Janzen (Doug) | Director of Issuer | Acquisition or disposition in the public market | Aug 18, 2022 | 38,779 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Natixis | 1.84% | 49,778 | 1.49M | Dec 30, 2022 |
| U.S. Capital Wealth Advisors, LLC | 0.69% | 18,780 | 563.96K | Dec 30, 2022 |
| Magnetar Financial LLC | 0.58% | 15,804 | 474.59K | Dec 30, 2022 |
| Choreo, LLC | 0.46% | 12,440 | 373.57K | Dec 30, 2022 |
| Morgan Stanley | 0.13% | 3,635 | 109.16K | Dec 30, 2022 |
| Bank of America Corporation | 0.10% | 2,701 | 81.11K | Dec 30, 2022 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.03% | 854 | 25.64K | Nov 29, 2022 |